In our present study, we show that miR-126 constrains the tumorigenesis of GCT via directly targeting EGFL7 and consequently suppresses the phosphatidylinositol 3-kinase/ATK (PI3K/AKT) pathway. This evidence concerns the gene EGFL7 and granular cell tumor.